George D. Yancopoulos
2008
In 2008, George D. Yancopoulos earned a total compensation of $1.9M as M.D., Ph.D. Executive Vice President, Chief Scientific Officer and President, Regeneron Research Laboratories at Regeneron Pharmaceuticals, a 87% decrease compared to previous year.
Compensation breakdown
Bonus | $325,655 |
---|---|
Option Awards | $1,003,970 |
Salary | $592,100 |
Other | $22,000 |
Total | $1,943,725 |
Yancopoulos received $1M in option awards, accounting for 52% of the total pay in 2008.
Yancopoulos also received $325.7K in bonus, $592.1K in salary and $22K in other compensation.
Rankings
In 2008, George D. Yancopoulos' compensation ranked 2,518th out of 9,135 executives tracked by ExecPay. In other words, Yancopoulos earned more than 72.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,518 | 72nd |
Manufacturing | 903 | 74th |
Chemicals And Allied Products | 155 | 81st |
Drugs | 91 | 85th |
Pharmaceutical Preparations | 70 | 83rd |
Yancopoulos' colleagues
We found four more compensation records of executives who worked with George D. Yancopoulos at Regeneron Pharmaceuticals in 2008.
2008
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2008
Robert Terifay
Regeneron Pharmaceuticals
Senior Vice President, Commercial
2008
Neil Stahl
Regeneron Pharmaceuticals
Senior Vice President, Research & Development Sciences
2008
Murray Goldberg
Regeneron Pharmaceuticals
Chief Financial Officer
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019